Cambridge, MA, United States of America

Kevin Struhl


Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • Weston, MA (US) (2003)
  • Cambridge, MA (US) (2023 - 2024)

Company Filing History:


Years Active: 2003-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kevin Struhl - A Pioneer in Cellular Transformation and Drug Resistance Research

Introduction

Kevin Struhl, a prominent inventor based in Cambridge, MA, has made significant contributions to the field of cellular biology and cancer research. Holding three patents, Struhl’s innovations focus on enhancing our understanding of cellular transformations and the mechanisms behind drug resistance in cancer therapy.

Latest Patents

Struhl's latest patents include two groundbreaking inventions. The first, titled "High-throughput dynamic reagent delivery system," pertains to a controlled fluidic device designed to create spatially complex environments. This invention aims to accelerate the rate of evolution in cell populations and provides crucial insights into the emergence of drug resistance during cancer chemotherapy.

His second patent, "High-throughput drug and genetic assays for cellular transformation," is a method for detecting oncogenic growth and viability. This method involves providing a cellular sample, such as cells from a subject or a cell line, culturing it under low-attachment conditions, and assessing growth or viability relative to control levels. The innovation also explores the introduction of expression vectors into cells to test transformation abilities and identify agents that may inhibit such transformations.

Career Highlights

Struhl has a distinguished career, with significant roles at esteemed institutions such as Harvard College and the Broad Institute, Inc. His work at these organizations has played a pivotal role in advancing cancer research and developing innovative methodologies in the field.

Collaborations

Throughout his career, Kevin Struhl has collaborated with notable colleagues, including Asaf Rotem and Zarmik Moqtaderi. These collaborations have further enriched his research and the impact of his inventions on the scientific community.

Conclusion

Kevin Struhl's contributions to the understanding of cellular transformation and drug resistance are invaluable to the realms of cancer research and biotechnology. His patented inventions are not only innovative but also instrumental in paving the way for future research and development in the fight against cancer. With a career marked by collaboration and groundbreaking discoveries, Struhl continues to inspire a new generation of scientists and inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…